Clinical TrialsSearch results
Number of results: 918
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Recruiting
- Treatment protocol for adult acute lymphoblastic leukemia (-ALL/MRD2023-)
- acute lymphoblastic leukemia
- Koichi Akashi
- 2022-11-24
Other
- Epidemic Research on Acute Mesenteric Ischemia in Japan
- Acute Mesenteric Ischemia
- National Hospital Organization Kumamoto Medical Center
- 2008-10-01
Other
- Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Other
- Investigational study for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Other
- Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study)
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2005-09-12
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2006-11-01
Other
- Biomarker study of Quizartinib resistance mechanisms and outcomes in patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia
- Acute myeloid leukemia
- Harada Mine
- 2020-05-27
Completed
- Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
- Acute Myeloid Leukemia
- Omote Masayuki
- 2022-11-29